A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...

Anti-LGBTQI+ public policies overwhelmingly target youth and young adults, disrupting access to educational opportunities, ...

In the absence of accessible, integrated, multidimensional patient data, the organ transplant system will remain both highly ...

The difficulty that stakeholders face in comparing contracts with different structures could be solved by a standardized ...

This article summarizes the provisions of the final 2026 HHS Notice of Benefit Payment Parameters related to the individual ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Don Berwick of the Institute for Healthcare Improvement about his paper as part of the Vital Directions for Health and Health Care: Priorities ...

Private equity (PE) acquisitions of health care providers are often framed as a monolithic intervention, but firms’ strategies for generating returns for investors may vary. In a ...

Consolidation of physician practices, largely driven by health systems, has motivated policy efforts to move care toward lower-price, non–health system settings. At the same time, however, private ...

Shifting from reducing MA capitation by an across-the-board coding intensity adjustment factor to Medicare Advantage ...

Victor J. Dzau ([email protected]), National Academy of Medicine, Washington, D.C. J. Michael McGinnis, National Academy of Medicine. In 2016, ahead of the US presidential election, the National ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

In a “rapid response” to the changing administration, authors write: “The current moment in American health care and politics presents new challenges but also new opportunities to advance the goals of ...